Metall Zug Ag Class B · SIX:METN

Metall Zug Ag Class B — FY2023 Earnings Presentation

49 slides from Metall Zug Ag Class B's earnings presentation, Mar 11, 2024

  1. Slide 1: Metall Zug AG - Welcome

    METALL ZUG AG - WELCOME Investor Presentation – March 11, 2024 Matthias Rey, CEO Urs Scherrer, CFO Bettine Killmer, Head of Corporate Communications & IR Investor Presentation - March 11, 2024 1

  2. Slide 2: What we planned and what we achieved 2023

    METALL ZUG GROUP WHAT WE PLANNED AND WHAT WE ACHIEVED 2023 − Maintain Gross Profit margin despite inflationary environment and price pressure on input side − Efficiency improvements in operations through further automation − R&D push: Further development of microscopy (analogue and digital), renewal

  3. Slide 3: Content

    METALL ZUG GROUP CONTENT 1. Group Financial Report 2023 2. Business Units − Infection Control − Joint Venture with Miele − Medical Devices − Others − Technologycluster & Infrastructure 3. Sustainability @ Metall Zug 4. Metall Zug Group – Outlook 2024 5. Information for Investors Investor Presentatio

  4. Slide 4: Group Financial Report FY 2023

    GROUP FINANCIAL REPORT FY 2023

  5. Slide 5: Overview FY 2023

    METALL ZUG GROUP OVERVIEW FY 2023 – Group net sales of CHF 494.7 million (FY 22: CHF 645.9 million; CHF 487.0 excl. Schleuniger), organic sales increase 6.4% – Negative FX effect of CHF –16.3 million (-3.3%), acquisition- & divestment effect of CHF -7.1 million (-1.5%) – Infection Control: Organic s

  6. Slide 6: Income Statement

    GROUP FINANCIAL REPORT INCOME STATEMENT 2022 excl. Schleuniger 2022 CHF million 2023 in % (pro-forma)* in % (reported) Comment Net sales 494.7 100.0 487.0 100.0 645.9 Cost of Goods and Services sold -343.1 -69.3 -324.1 -66.6 -419.2 Gross profit 151.7 30.7 162.9 33.4 226.7 Maketing and sales expenses

  7. Slide 7: Associated Companies

    GROUP FINANCIAL REPORT ASSOCIATED COMPANIES In CHF million FY 2023 Komax V-ZUG Total Pro rata net result 14.3 4.3 18.6 Adjustment to previous year's actual result -0.4 -1.2 -1.6 Total result 13.9 3.1 17.0 Book value (proportional equity) 107.7 141.3 249.0 Market value (share price as of December 31)

  8. Slide 8: Net Sales FY 23

    GROUP FINANCIAL REPORT NET SALES FY 23 by Business Unit by region Asia/Pacific/Others 15% Switzerland (17%) 17% (12%) Medical Devices 38% (46%) Others 24% (17%) Americas 35% Europe w/o (41%) Switzerland Infection Control 33% 38% (30%) (37%) (Previous year’s values in brackets – excluding Wire Proces

  9. Slide 9: Net Sales Analysis

    GROUP FINANCIAL REPORT NET SALES ANALYSIS ORGANIC GROWTH EXTERNAL FX GROUP REPORTED Net sales in CHF million Investor Presentation - March 11, 2024 9

  10. Slide 10: Operating Result (EBIT) Analysis

    GROUP FINANCIAL REPORT OPERATING RESULT (EBIT) ANALYSIS OPERATIONAL (BUs) EXTERNAL GROUP REPORTED EBIT in CHF million Investor Presentation - March 11, 2024 10

  11. Slide 11: Balance Sheet

    GROUP FINANCIAL REPORT BALANCE SHEET CHF million 12/31/2023 in % 12/31/2022 in % Comment Cash and cash equivalents / securities 29.8 4.3 31.7 4.5 Other current assets 208.7 30.2 254.2 36.2 Current assets 238.5 34.5 285.9 40.8 Tangible assets 169.6 24.5 154.9 22.1 Includes participation (equity value

  12. Slide 12: Cash Flow Statement

    GROUP FINANCIAL REPORT CASH FLOW STATEMENT 2022 excl. 2022 CHF million 2023 Schleuniger Comment (reported) (pro-forma)* Cash flow from operating activities 9.5 -0.5 -6.0 Cash flow from investing activities -16.4 -36.8 -42.1 2023: Investments in real estate projects of Tech Cluster as well as - of wh

  13. Slide 13: Business Units

    NG _ azz METALL ZUG BUSINESS UNITS

  14. Slide 14: Infection Control

    INFECTION CONTROL 2023: NET SALES CHF 186.0 MILLION; EBIT CHF -2.8 MILLION Investor Presentation - March 11, 2024 14

  15. Slide 15: Infection Control: Key Figures and Overview

    INFECTION CONTROL KEY FIGURES AND OVERVIEW CHF million FY 2023 FY 2022 Δ Net Sales by region 6% Net sales 186.0 1) 186.3 -0.2% 23% (6%) (22%) Operating result (EBIT) -2.8 1.7 2) -264.7% Switzerland EBIT margin in % -1.5 0.9 -240bp 1) Includes acquisition effect Amity Ltd. of CHF 2.0 million Europe (

  16. Slide 16: Joint Venture with Miele: Background

    JOINT VENTURE WITH MIELE FOR INFECTION CONTROL AND LIFE SCIENCE BACKGROUND OF THE JOINT VENTURE – JV to be established in Zug – Metall Zug will contribute Infection Control Business Unit and Belimed Life Science Group (Reporting Segment Others), and Miele its stake in Steelco S.p.A. – Infection Cont

  17. Slide 17: Joint Venture with Miele: Strategic Picture

    JOINT VENTURE WITH MIELE FOR INFECTION CONTROL AND LIFE SCIENCE STRATEGIC PICTURE Success factors Life Market Players and Full solutions offering with large product Time sales approach (2022) portfolio, service and consumables Getinge - illustrative - 724 M€ Steris Handling of complex tenders in pri

  18. Slide 18: Joint Venture Timeline

    JOINT VENTURE WITH MIELE FOR INFECTION CONTROL AND LIFE SCIENCE TIMELINE Signing Closing expected End of integration 2034: JV is laid-out November, 2023 HY 1, 2024 phase, 2027 for 10 years PMI Execution Review by relevant competition authorities Growth phase Development of Target Picture Metall Zug

  19. Slide 19: Medical Devices

    MEDICAL DEVICES 2023: NET SALES CHF 178.3 MILLION; EBIT CHF 15.2 MILLION Investor Presentation - March 11, 2024 19

  20. Slide 20: Medical Devices: Key Figures and Overview

    MEDICAL DEVICES KEY FIGURES AND OVERVIEW CHF million FY 2023 FY 2022 Δ Net Sales by region 16% 5% Net sales 178.3 1) 225.6 -21.0% (15%) (4%) Operating result (EBIT) 15.2 2) 28.8 3) -47.2% Switzerland EBIT margin in % 8.5 12.8 -430bp Europe (excl. CH) 1) Includes divestment effect Clement Clarke Inte

  21. Slide 21: Medical Devices: Strategic Priorities

    MEDICAL DEVICES STRATEGIC PRIORITIES – Focus on eyecare, mainly ophthalmology – Complementing and expanding solution portfolio including digitalization, artificial intelligence and data processing – Expanding training portfolio by increasing simulation and training opportunities for ophthalmologists

  22. Slide 22: Others: Belimed Life Science, Gehrig Group

    OTHERS: BELIMED LIFE SCIENCE, GEHRIG GROUP, METALL ZUG AG (CORPORATE) 2023 : NET SALES CHF 117.3 MILLION; EBIT CHF -4.0 MILLION Investor Presentation - March 11, 2024 22

  23. Slide 23: Others: Key Figures and Overview

    OTHERS KEY FIGURES AND OVERVIEW CHF million FY 2023 FY 2022 Δ Net sales 117.3 86.2 36.1% Operating result (EBIT) -4.0 82.6 1) -104.8% EBIT margin in % -3.4 95.8 -9920bp 1) Includes CHF 89.7 million book-gain from the deconsolidation of the Schleuniger Group Belimed Life Science – High order backlog

  24. Slide 24: Technologycluster & Infrastructure

    TECHNOLOGYCLUSTER & INFRASTRUCTURE 2023 : NET SALES CHF 19.6 MILLION; EBIT CHF 5.2 MILLION Tech Cluster Zug Grienbachstrasse 11 Mobility Hub Pi CHF million FY 2023 FY 2022 Δ Net sales 19.6 1) 0.0 n/a Operating result (EBIT) 5.2 1) 2.9 79.3% EBIT margin in % n/a n/a n/a 1) Net sales of CHF 19.6 milli

  25. Slide 25: Tech Cluster Zug – Significant Development Potential

    TECHNOLOGYCLUSTER & INFRASTRUCTURE TECH CLUSTER ZUG – SIGNIFICANT DEVELOPMENT POTENTIAL Current projects Total area potential - Development area (ground): approx. refActory 46’200 m2, plus Grienbachstrasse (5’500 m2) - Building volume TCZ: Up to 1’342’600 m3 incl. V-ZUG and Mobility Hub Zug Nord, re

  26. Slide 26: Tech Cluster Zug – Major Rental Projects

    TECHNOLOGYCLUSTER & INFRASTRUCTURE TECH CLUSTER ZUG – MAJOR RENTAL PROJECTS SHL Südtor refActory 102’632 m3 building volume 41’300 m3 building volume 11’140 m2 production area 45 parking lots Project size 5’100 m2 office space 84 parking lots Showroom and museum V-ZUG, Usage Combined production and

  27. Slide 27: Tech Cluster Zug / Others – Major Sales Projects

    TECHNOLOGYCLUSTER & INFRASTRUCTURE TECH CLUSTER ZUG / OTHERS – MAJOR SALES PROJECTS CreaTower I Project Pi (not part of TCZ development plan area) 35’696 m3 building volume 95’195 m3 building volume 892 m2 ground to be sold Approx. 16’500 m2 living space Project size 6’863 m2 office space (One of th

  28. Slide 28: Investments in Real Estate Development Projects

    TECHNOLOGYCLUSTER & INFRASTRUCTURE INVESTMENTS IN REAL ESTATE DEVELOPMENT PROJECTS CAPEX of major TCZ rental projects / rental income In the current environment, Metall Zug is CHF million (Mobility Hub Zug Nord, Westhive, SHL Südtor & refActory) aiming for a net return of around 3% also taking into

  29. Slide 29: Realization of Property Value

    TECHNOLOGYCLUSTER & INFRASTRUCTURE REALIZATION OF PROPERTY VALUE - Land currently recognized at cost (CHF 24.9 million, respectively CHF 36.0 million including Grienbachstrasse 11 and Pi) - Fair value of Tech Cluster significantly above cost; strongly impacted by building volume, type of usage and t

  30. Slide 30: Sustainability @ MZ

    NG _ azz METALL ZUG SUSTAINABILITY @ MZ

  31. Slide 31: Medium-term Sustainability Targets

    SUSTAINABILITY MEDIUM-TERM SUSTAINABILITY TARGETS Investor Presentation - March 11, 2024 31

  32. Slide 32: Medium-term Sustainability Targets

    SUSTAINABILITY MEDIUM-TERM SUSTAINABILITY TARGETS Investor Presentation - March 11, 2024 32

  33. Slide 33: Medium-term Sustainability Targets

    SUSTAINABILITY MEDIUM-TERM SUSTAINABILITY TARGETS Investor Presentation - March 11, 2024 33

  34. Slide 34: Greenhouse Gas Fund

    SUSTAINABILITY GREENHOUSE GAS FUND – Since implementation, the Metall Zug Group has allocated around CHF 4.3 million to the Greenhouse Gas Fund (GHG) – For 2024, around CHF 1.6 million have been earmarked for MZ Group projects – All Business Units have received at least one project commitment Projec

  35. Slide 35: Verein zur Dekarbonisierung der Industrie

    SUSTAINABILITY VEREIN ZUR DEKARBONISIERUNG DER INDUSTRIE H2 Project@Tech Cluster Zug: – The “Verein zur Dekabonisierung der Industrie”(VzDI) will forge ahead innovative hydrogen project – Hydrogen shall be produced for the first time from the pyrolysis of methane (biogas or natural gas) on an indust

  36. Slide 36: ESG Targets – Key Performance Indicators

    SUSTAINABILITY ESG TARGETS – KEY PERFORMANCE INDICATORS − ESG targets and activities are measured in a set of KPIs − In 2022, the targets were systematically linked to measurable key figures for each focus topic − The set of key figures is reported by all companies of Metall Zug Group Investor Prese

  37. Slide 37: ESG Targets – KPIs Climate & Resources

    SUSTAINABILITY ESG TARGETS – KPIS CLIMATE & RESOURCES Investor Presentation - March 11, 2024 37

  38. Slide 38: ESG Targets – KPIs Employees

    SUSTAINABILITY ESG TARGETS – KPIS EMPLOYEES Investor Presentation - March 11, 2024 38

  39. Slide 39: ESG Targets – KPIs Products and Services

    SUSTAINABILITY ESG TARGETS – KPIS PRODUCTS AND SERVICES Investor Presentation - March 11, 2024 39

  40. Slide 40: Metall Zug Group 2024

    NG _ azz METALL ZUG METALL ZUG GROUP 2024

  41. Slide 41: Outlook 2024

    METALL ZUG GROUP OUTLOOK 2024 − In 2023 noticeable decline in order intake and order backlog − In the first months of 2024, only isolated signs of improvement in this situation − Planned joint venture with Belimed and Steelco will result in deconsolidation of Belimed Infection Control and Belimed Li

  42. Slide 42: What we plan for 2024

    METALL ZUG GROUP WHAT WE PLAN FOR 2024 − Increase sales with a focus on US and Asian markets − Review the implementation of strategic initiatives − R&D push: Further development of microscopy (analogue and digital), digitalization of devices and product updates − Successful closing of joint venture

  43. Slide 43: A Solid Investment with Potential

    METALL ZUG GROUP A SOLID INVESTMENT WITH POTENTIAL – Three strategic pillars of Metall Zug Group: Ophthalmology (Medical Devices), Tech Cluster Zug and anchor participations – Earnings growth drivers are – Foster operational excellence and explore the full growth potential with an R&D push by Medica

  44. Slide 44: Information for Investors

    Me _ azz METALL ZUG INFORMATION FOR INVESTORS

  45. Slide 45: Share Price Development

    METALL ZUG GROUP SHARE PRICE DEVELOPMENT CHF Share price development 6’000 5’000 4’000 3’000 2’000 1’000 0 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Metall Zug V-ZUG ZugEstates Investor Presentation - March 11, 2024 45

  46. Slide 46: Reconciliation of Pro-forma Financial Information

    METALL ZUG GROUP RECONCILIATION OF PRO-FORMA FINANCIAL INFORMATION INCOME STATEMENT: – The pro forma Income Statement 2022 was adjusted for the contribution from and the deconsolidation of Schleuniger as follows: Net Sales CHF -159.0 million, EBIT CHF -20.0 million, Financial result CHF 1.0 million,

  47. Slide 47: Financial Calendar

    METALL ZUG GROUP FINANCIAL CALENDAR April 26, 2024 Ordinary Annual General Meeting of Shareholders 2024 May 3, 2024 Dividend Payment August 8, 2024 Half Year Results 2024 Investor Presentation - March 11, 2024 47

  48. Slide 48: Contact

    METALL ZUG GROUP CONTACT Urs Scherrer CFO Bettine Killmer Head of Corporate Communications & Investor Relations Metall Zug AG Industriestrasse 66 6302 Zug Switzerland Phone: +41 58 768 60 50 Investor Presentation - March 11, 2024 48

  49. Slide 49: Disclaimer

    METALL ZUG GROUP DISCLAIMER Metall Zug AG has made great efforts to include accurate and up-to-date information in this document. However, we make no representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided in this document and disclaim any

Metall Zug — FY2023 Earnings Presentation on 6ix